WO2004065928A2 - Light induced immobilisation - Google Patents
Light induced immobilisation Download PDFInfo
- Publication number
- WO2004065928A2 WO2004065928A2 PCT/DK2004/000047 DK2004000047W WO2004065928A2 WO 2004065928 A2 WO2004065928 A2 WO 2004065928A2 DK 2004000047 W DK2004000047 W DK 2004000047W WO 2004065928 A2 WO2004065928 A2 WO 2004065928A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- protein
- carrier
- cutinase
- peptide
- amino acid
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/14—Enzymes or microbial cells immobilised on or in an inorganic carrier
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/01—Carboxylic ester hydrolases (3.1.1)
- C12Y301/01074—Cutinase (3.1.1.74)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
Definitions
- the present invention relates to a method of cross-linking or immobilising proteins on a carrier.
- Molecules can be immobilised on a carrier or solid surface either passively through hydrophobic or ionic interactions, or covalently by attachment to activated surface groups.
- immobilisation for solid phase chemistry and biological screening, the analytical uses of the technology have been widely explored.
- the technology has found broad application in many different areas of biotechnology, e.g. diagnostics, biosensors, affinity chromatography and immobilisation of molecules in ELISA assays.
- the value of immobilisation technology is demonstrated by the recent development of DNA microarrays, where multiple oligonucleotide or cDNA samples are immobilised on a solid surface in a spacially addressable manner.
- Other functional groups on the surface of proteins which can be used for attachment to an appropriate surface include reacting an amine with an aldehyde via a Schiff-base, cross-linking amine groups to an amine surface with gluteraldehyde to form peptide bonds, cross-linking carboxylic acid groups present on the protein and support surface with carbodiimide, cross-linking based on disulfide bridge formation between two thiol groups and the formation of a thiol-Au bond between a thiol group and a gold surface.
- N- hydroxysuccinimide esters are formed from a fraction of the carboxyl groups of the carboxymethyldextran matrix via reaction with N-hydroxysuccinimide (NHS) and N-ethyl-N'-(dimethylaminopropyl) carbodiimide hydrochloride (EDC) in water, which then react spontaneously with amine groups on a protein to form covalent bonds (Johnsson B., et. al., 1991 , Anal Biochem 198:268-77).
- NHS N-hydroxysuccinimide
- EDC N-ethyl-N'-(dimethylaminopropyl) carbodiimide hydrochloride
- Mutant plastocyanin expressed intracellularly in bacteria, is exposed to a reducing environment in the cytoplasm, such that the inserted cysteines are reduced, and can thus mediate the direct adsorption of the isolated protein onto a gold substrate.
- the thiol group binding properties of the protein are thus dependent on in vivo or in vitro chemical reduction of the cysteine residues on the surface of the protein.
- the RNase was coupled to the iodoacetyl groups attached to a cross-linked agarose resin, without loss of enzymatic activity. Again, preparation of the protein for immobilisation requires its exposure to both protecting and de- protecting agents, which may negatively impact its native structure and/or function.
- Bifunctional agents possessing thermochemical and photochemical functional substituents for immobilising an enzyme are disclosed in US 3,959,078. Derivatives of arylazides are described which allow light mediated activation and covalent couping of the azide group to an enzyme, and substituents which react thermochemically with a solid support. The orientation of the enzyme molecules immobilised by this procedure is not controlled.
- a method for orientated, light-dependent, covalent immobilization of proteins on a solid support, using the heterobifunctional wetting-agent N-[m-[3- (trifluoromethyl)diazirin-3-yl]phenyl]-4-maleimidobutyramine, is described in WO 91 16425 and by Collioud A et al. (1993) in Bioconjugate Chem. 4: 528- 536.
- the aryldiazirine function of this cross-linking reagent facilitates light- dependent, carbene-mediated, covalent binding to either inert supports or to biomolecules, such as proteins, carbohydrates and nucleic acids.
- the maleimide function of the cross-linker allows binding to a thiolated surface by thermochemical modification of cysteine thiols. Orientated binding of this cross-linking reagent to a protein can be attained by a thermochemical interaction between the maleimide function and an exposed thiol group on the protein surface, however this treatment may modify the structure and activity of the target protein.
- Light-induced covalent coupling of the cross- linking reagent to a protein via the carbene function has the disadvantage that it does not provide for controlled orientation of the target protein.
- thermochemical/chemical steps sometimes with hazardous chemicals, some of which are likely to have a deleterious effect on the structure and/or function of the bound protein.
- hazardous chemicals some of which are likely to have a deleterious effect on the structure and/or function of the bound protein.
- the available methods are often invasive, whereby foreign groups are introduced into a protein to act as functional groups, which cause protein denaturation, as well as lower its biological activity and substrate specificity.
- the present invention provides a method for coupling a protein or a peptide on a carrier via stable bonds (covalent bond or thiol-Au bond) while preserving the native structural and functional properties of the coupled protein or peptide, and avoiding the use of one or more chemical steps.
- the orientation of the protein or peptide, coupled according to the method of the present invention can be controlled, such that their functional properties e.g. enzymatic, may be preserved.
- the invention exploits an inherent property of proteins and peptides, whereby a disulfide bridge in a protein or peptide, located in close proximity to an aromatic amino acid residue, is disrupted following prolonged irradiation with light absorbed by these aromatic amino acids.
- the thiol groups created by light-induced disulfide bridge disruption in a protein or peptide are then used to immobilise the protein or peptide to a carrier.
- a method of coupling a disulfide bridge containing protein or peptide on a carrier comprising the following steps of irradiating a protein or peptide creating a thiol group, and incubating the irradiated protein or peptide with a carrier capable of binding a thiol group.
- Coupling according to the invention is furthermore possible by incubating the protein or peptide together with a carrier capable of binding a thiol group and r irradiating the protein or peptide in the presence of the carrier to create a thiol group in the protein or peptide, and thereby obtaining a coupling to the thiol ligand binding group on the carrier.
- the irradiation comprises light of a wavelength that excites one or more aromatic amino acids.
- the irradiated aromatic amino acid in the protein may comprise tryptophan, tyrosine and phenylalanine, or alternatively the aromatic amino acid is tryptophan.
- the irradiation comprises wavelengths in the vicinity of 295nm, 254nm or 275nm.
- the irradiated protein or peptide is coupled to a carrier that comprises a peptide or protein or any other biomolecule.
- the irradiated protein or peptide is coupled to a support which comprises gold, or is derivatised with a thiol binding group, or comprises a thiol group or a disulfide bridge, where coupling to the support may be an immobilisation.
- the carrier or support comprises a spacer.
- a carrier or support comprising the coupled protein or peptide, produced according to the disclosed method of coupling a protein or peptide on a carrier.
- the protein or peptide, coupled according to the disclosed method of coupling a protein or peptide on a carrier includes enzymes, transcription factors, protein domains, antigens, antibodies or binding proteins as well as other proteins or peptides.
- the carrier, coupled according to the disclosed method of coupling a protein or peptide on a carrier includes a pharmaceutical drug.
- the carrier or support comprising the coupled protein, produced according to the disclosed method of coupling a protein or peptide on a carrier, for bio-functional assays or in a kit providing for biofunctional assays.
- bio-functional assays comprises: bio-sensors, chromatography, immunodetection, enzyme assays, nucleotide binding detection, protein- protein interaction, protein modifications, carrier targeting or protein targeting.
- a method is provided for identifying a disulfide bridge containing protein or peptide capable of disruption by irradiation.
- Figure 1 shows the cutinase fluorescence emission intensity at 350 nm as a function of time of illumination at 295 nm.
- Figure 2 shows the coupling reaction between an SH group of a protein and an SS group of 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB) and the stoichiometric release of nitrothiobenzoate (NTB).
- DTNB 5,5'-dithiobis-(2-nitrobenzoic acid)
- Figure 3 shows the Trp fluorescence (F) emission intensity increase of cutinase at 350 nm [F/Fo] as a function of time of illumination at 295 nm (solid line) and the concentration of newly formed free thiol groups in cutinase samples with specific ratios of fluorescence emission increase [F/Fo] (open circles).
- Figure 4 shows the fluorescence emission spectrum of a 1 ⁇ M cutinase solution upon excitation with 295 nm light during incubation (A) at 25°C without DTT [solid circles]; (B) at 70°C without DTT [solid black line]; (C) at
- Figure 5 shows spectral characteristics of aromatic amino acid residues in aqueous solution at pH 7.0.
- Figure 6 shows the structure of the intramolecularly quenched probe Bodipy FL- L-Cystine, whose SS bond break in the presence of free SH groups, resulting in fluorescence of the Bodipy groups.
- Figure 7 shows detection of free SH groups in a protein sample before and after UV illumination at 296nm by reaction with Bodipy FL- L-Cystine.
- Bodipy group fluorescence emission spectrum of mutant cutinase (W69A) A
- native cutinase (B) protein samples is shown for: non-illuminated and
- Bodipy probe minus Bodipy probe ( ); non-illuminated with Bodipy probe (•) and illuminated
- Figure 8 shows detection of free SH groups in a protein sample before and after UV illumination at 296nm by reaction with Bodipy FL- L-Cystine.
- Bodipy group fluorescence emission spectrum of hen white lysosyme (A); Rhizopus niveus triglyceride lipase (B); human plasminogen (C); human placental alkaline phosphatase (D); chymosin (E); human immunoglobulin (F) protein samples is shown for: non-illuminated and minus Bodipy probe; non-illuminated with Bodipy probe; and illuminated with bodipy treatments.
- Figure 9 shows the contour plots of different spatial Trp S-S triad neighbourhood spheres within a radius of 8A.
- the different triads are plotted along the x-axis, and ranked according to their similarity to the cutinase triad (1cex; ranked No.1) and the different groups of residues are plotted along the y-axis.
- a score of >1 means that a residue/group is over-represented, while a score of ⁇ 1 means that a residue/group is under-represented.
- Figure 10 shows the contour plots of different spatial Trp S-S triad neighbourhood spheres within a radius of 8A.
- the different triads are plotted along the x-axis, and ranked according to their similarity to the cutinase triad (1cex; ranked No.1 ) and the different groups of residues are plotted along the y-axis.
- a score of >1 means that a residue/group is over-represented, while a score of ⁇ 1 means that a residue/group is under-represented.
- Trp60-Cys73- Cys91 is found to be disruptable on UV irradiation, while Trp118-Cys28- Cys111 is not disruptable.
- Figure 11 shows the contour plots of different spatial Trp S-S triad neighbourhood spheres within a radius of 8A identified in IGG1 triads A present in immunoglobulins.
- the different triads are plotted along the x-axis, and ranked according to their similarity to the cutinase triad (1cex; ranked No.1 ) and the different groups of residues are plotted along the y-axis.
- a score of >1 means that a residue/group is over-represented, while a score of ⁇ 1 means that a residue/group is under-represented.
- Figure 12 shows the contour plots of different spatial Trp S-S triad neighbourhood spheres within a radius of 8A identified in IGG1 triads B present in immunoglobulins.
- the different triads are plotted along the x-axis, and ranked according to their similarity to the cutinase triad (1cex; ranked No.1) and the different groups of residues are plotted along the y-axis.
- a score of >1 means that a residue/group is over-represented, while a score of ⁇ 1 means that a residue/group is under-represented.
- Figure 13 shows a time course of fluorescence emission at 330nm, on excitation at 296nm, detected in a TIRF flow cell during cutinase immobilisation on a SH-activated quartz slide under continuous or limited illumination at 296nm.
- the flow chamber in step A is flushed with 2.0 ⁇ M cutinase solution; step B: incubated with 2.0 ⁇ M cutinase solution; step C/D: rinsed with buffer A; and step E: rinsed with detergent and buffer A.
- Figure 14 A shows the final fluorescence emission intensity (at 330nm, on excitation at 296nm) of native cutinase immobilised on a SH-activated or a hydroxylated quartz slide, under continuous or limited illumination.
- B shows the final fluorescence emission intensity (at 330nm, on excitation at 296nm) of native cutinase and mutant cutinase (W69A) immobilised on a SH- activated quartz slide, under continuous illumination or in the dark.
- Figure 15 shows fluorescence emission intensity (at 450nm, on excitation at 365nm) of 4-methylum-belliferylbutyrate hydrolysed by cutinase immobilised on either SH-activated or hydroxylated quartz slides by UV-illumination.
- Figure 16 shows a time course of fluorescence emission at 330nm, on excitation at 296nm, detected in a TIRF flow cell during (A) lysozyme (B) lysosyme and (C) chymosin immobilisation on a SH-activated or a hydroxylated quartz slide on 10 min continuous illumination (A), or continuous illumination (C) at 296nm, and in the dark (B).
- step (a/A) the flow chamber in step (a/A) is incubated with the protein (lysosyme or chymosin) 10 minutes (initial 6.66 minutes with flushing/flow); in step (b/B) is washed with buffer for 10 minutes (initial 6.66 minutes with flushing/flow); in step (c/C) is washed with Helmanex, 2% pH 10-11 4-5 minutes (initial 3.33 minutes with flushing/flow); and in step (d/D) is washed with buffer for remaining reading (Initial 3.33 minutes with flow).
- protein lysosyme or chymosin
- Figure 17 A shows relative activity of a cutinase sample (compared to a sample placed in the dark) as a function of illumination at 296nm or placed in laboratory light.
- B shows relative activity of a cutinase sample in the presence of 5.1 mM DTT (•,•), or without DTT (o ). The data point at 300 min for the sample without DTT was measured at 1600 min.
- UV light or “irradiation” or UV illumination” or “UV irradiation” is a range of wavelengths or single wavelength of UV light, or IR/visible light for multiphoton excitation, that specifically excites aromatic amino acids, or other aromatic system that may mimic aromatic amino acids, preferably a wavelength of approximately 295 nm, 275 nm or 254 nm, more preferably the wavelengths that excite tryptophan, tyrosine or phenylalanine, most preferably the wavelength, 295 nm, that excites tryptophan.
- protein comprises polypeptides, fragments of proteins and antibodies or any other amino acid based material. Furthermore the term “protein” includes enzymes, antibodies, antigens, transcription factors, binding proteins e.g. DNA binding proteins, or protein domains.
- spatial neighbour relates to the physical distance between two chemical groups within a composition, such that groups lying in three-dimensional close proximity are considered to be spatial neighbours.
- a disulfide bridge in a protein that is a spatial neighbour to an aromatic residue may function as a quencher if the aromatic amino acid absorbs excitation energy following irradiation.
- the physical distance between half cystines of a disulfide bridge, which are spatial neighbours to tryptophan residues and may act as quenchers, can be, but is not limited, a range of 1 to 10 A.
- carrier can be a soluble compound or polymer, or an insoluble compound or polymer, where the compound or polymer comprises a thiol-binding ligand, such as a reactive SH or an SS bond capable of coupling to an irradiation-induced thiol group.
- carrier can also be another biomolecule, for example another protein, peptide or polypeptide.
- carrier should be understood to include supports comprising material capable of coupling to an irradiation-induced thiol group, such as a gold support or a derivatised support carrying a thiol- binding ligand.
- the term "support” can be any support material such as ⁇ electronic chips, slides, wafers, particles, resins, wells, tubes or membranes which include but are not limited to any material comprising polymers such as Topaz, polystyrene, polyethylene, polyester, polyethermides, polypropylene, polycarbonate, polysulfone, polymethylmethacrylate [PMMA], poly(vinylidene flouride) [PVDF], silicone; diamond; glass e.g. quartz and silica; silicium e.g. silicium wafers; metals; membranes e.g. nylon membranes, nitrocellulose filters; porous materials such as gels, agarose or cellulose; ceramics etc, which furthermore include all forms of derivatisation of the support which facilitate binding of thiol groups with or without intervening spacers.
- polymers such as Topaz, polystyrene, polyethylene, polyester, polyethermides, polypropylene, polycarbonate, polysulfone, polymethyl
- spacer comprises a chain of compounds with the purpose of providing a link between a protein and a carrier or raising an immobilised protein above the surface of a support.
- the term 'pharmaceutical drug' comprises articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in man or other animals; and articles (other than food) intended to affect the structure or any function of the body of man or other animals and articles intended for use as a component of any article specified above.
- bio-functional assay comprises a biosensor, immunodetection, an enzyme assay, nucleotide-binding detection, chromatography, protein-protein interaction, protein modification, carrier targeting or protein targeting.
- biosensor comprises an analytical devise incorporating biological or biologically-derived sensing elements, such as an amino acid (e.g., cysteine), protein, antibody, nucleic acid, microorganism, or cell.
- the sensing element is either integrated within or intimately associated with a physicochemical transducer.
- the general aim of a biosensor is to produce either discrete or continuous digital electronic signals that are proportional to a single analyte or a related group of analytes.
- the present invention exploits an inherent property of proteins, concerning irradiation-induced structural changes in proteins, thought to retard their photo-degradation.
- proteins When proteins are exposed to UV irradiation some disulfide bridges are disrupted to form activated thiols.
- disulfide bridges are commonly found in the structural core and near/on the surface of folded proteins, those located in close proximity to aromatic amino acids are the most susceptible to UV-induced disruption.
- energy absorbed by side chains of aromatic amino acid residues are transferred to neighbouring disulfide bridges, which function as quenchers (Neves-Petersen MT., et al., 2002, Protein Science 11 : 588-600).
- Cutinase from the fungus Fusarium solani pisi, is one of several model proteins that are provided to illustrate the process of light-induced disulfide bridge reduction and their immobilisation on a carrier, however the application of the invention is by no means limited to a model protein.
- Cutinase is a lipolytic enzyme capable of degrading cutin, an insoluble lipid- polyester matrix found on the surface of plant leaves. Cutinase is an industrially important enzyme, and it is proposed to incorporate in detergents for the removal of fats. It has two disulphide bridges; one near the active site, and one distal at the opposite pole of the protein, in close proximity to the single tryptophan residue of the protein. Chemical reduction of the disulphide bridge, located near the active site, renders the enzyme inactive (Soliday CL, et. al., 1983, Biochem Biophys Res Commun 114:1017-22).
- Disulphide bridges are known to be excellent quenchers of excited-state aromatic residues. Any aromatic residue, which is in close spatial proximity, can cause photo-induced disruption of a neighbouring disulfide bridge. Hence the three aromatic amino acids, tryptophan, tyrosine and phenylalanine found in proteins, are all potential mediators of light-induced disulfide bridge disruption. While irradiation with light of a range of wavelengths extending from 240nm to 300nm will excite all aromatic residues, the individual aromatic residues have differing absorption maxima (Table 1 ; data obtained at neutral pH).
- electronic excitation of tryptophan can both be achieved with ultraviolet light at 295 nm, or with two-photon excitation at a wavelength of approximately 690 nm.
- excited tyrosine residues can cause the excitation of neighbouring tryptophan residues by a mechanism called fluorescence resonance energy transfer, which in turn can cause disulfide bridge disruption.
- Disulphide bridges placed in the spatial vicinity of aromatic amino acid residues are likely to be the most labile to UV light.
- the 3D structures of a subset of proteins containing the spatial triad Trp Cys-Cys, in close spatial proximity, have been examined in order to identify which amino acids are located in immediate vicinity of the tryptophan residues of the triad.
- the amidic amino acid residues (Asn, Gin) are over- represented, and in the majority of cases the occurrence of short aliphatic residues (Gly, Ala, Val) and/or long aliphatic residues (Leu, lie) are also over- represented. Comparing the 8 Angstr ⁇ m map to the 12 Angstr ⁇ m and the 15 Angstr ⁇ m maps it can be observed how the contours of the map fade.
- the amino acid composition of the subsets approaches the composition of the average protein. An observation that can be made on all of the three maps is that in almost every triad there is an under-representation of the groups of charged amino acids (His, Lys, Arg)(Asp, Glu) and proline residues.
- the amino acid residues located within an 8A radius proximity of Trp-SS triads of immunoglobulins have an over-representation of hydroxyl- containing amino acids, and in many IgG Trp S-S triads the aromatic residues are also over-represented.
- One or both amidic amino acids (Asn, Gin) and the occurrence of aliphatic residues are also over-represented in the many immunoglobulins whose amino acid composition around the TrpSS spatial triad closely resembles the composition around the cutinase triad (immunoglobulins part of the IGG1 triads A group).
- Irradiation with 295 nm light is preferable since it permits the selective excitation of tryptophan residues in a protein, which in turn may lead to the disruption of a single or a limited number of disulfide bonds.
- a variety of light sources suitable for the irradiation of proteins at a range of wavelengths, for the photo-induction of disulfide bond disruption include, but are not limited to, a 75-W Xenon arc lamp from a research grade spectrometer such as a RTC PTI spectrometer, a deuterium lamp, a high pressure mercury lamp. Irradiation at a single wavelength can be obtained by coupling the light source to a monochromator.
- a source of single and multiple photon excitation includes a high peak-power pulsed or CW laser.
- New thiol groups are formed in proteins following light-induced disulfide bond disruption. Their appearance de novo can be measured by a 5,5'-dithiobis-(2- nitrobenzoic acid) [DTNB] based assay.
- DTNB 5,5'-dithiobis-(2- nitrobenzoic acid)
- This method of coupling to a carrier can be used to construct various types of disulfide-linked oligomers or polymers.
- Light-induced thiol groups in a given protein or peptide or other biomolecule can be coupled to a carrier comprising a peptide or protein.
- concentration of protein and carrier molecules in the coupling reaction is sufficiently high, SS based cross-linking between neighbouring molecules will take place. While the light- induced protein should contain an SS bridge, the possession of an aromatic residue as close spacial neighbour is not essential, since the aromatic contribution to the reaction may be supplied by aromatics residues, or compounds that can mimic them, added to the coupling reaction.
- This method of light-induced thiol coupling to a carrier can be usefully applied to other types of carrier molecule, such as pharmaceutical drugs, in order to facilitate their effective delivery.
- carrier molecule such as pharmaceutical drugs
- light-induced thiol coupling of a water-soluble molecule containing a disulfide bridge (including but not limited to a peptide or protein) to a drug can help the solubilisation and delivery of water-insoluble, poorly soluble or hydrophobic drugs.
- the molecule coupled to the drug may serve to protect the drug from its physiological environment, and hence improve its stability in vivo. This particular feature makes this technology attractive for the delivery of labile drugs such as proteins.
- Carrier-linked prodrugs are generally defined as prodrugs that contain a temporary linkage of a given active substance to a transient carrier group that produces improved physicochemical or pharmacokinetic properties and that can be easily removed in vivo, usually by a hydrolytic cleavage.
- light-mediated disruption of the disulfide bond linking a drug to a molecule can be used to achieve a controlled release of the active drug from the molecule-coupled form, implanted in the patient. This would minimise the frequency of drug delivery to the patient, and provide for light-controlled dosing.
- This method of light induced thiol coupling can also be used to immobilise a protein on a support.
- the most common types of bonds that are formed during coupling to a support are disulfide bonds and sulfur-metal bonds (primarily sulfur-gold) where a self-assembled layer is formed. As both types of bonds are stable, extensive washing after immobilization will not displace the protein.
- the density of proteins on a support can be controlled by varying the protein concentration, or the intensity and duration of UV-irradiation, and subsequently blocking the remaining activated thiol groups on the surface with reagents such as L-cysteine, (2-(2-pyridinyldithio)ethaneamine hydrochloride (PDEA) or with a thiol-lipid bilayer (Hong Q., et. al., 2001 , Biochemical Society Transactions 29(4):587-582).
- PDEA 2-(2-pyridinyldithio)ethaneamine hydrochloride
- the support, with evenly distributed immobilized proteins, is therefore blocked to prevent non-specific binding.
- the method of immobilization does not involve any chemical steps, since the thiol-activated proteins formed by UV radiation, spontaneously self-assemble on the support.
- a particular advantage of the present invention is its avoidance of the several disadvantages associated with the chemical generation of free thiols in a protein.
- Some proteins, e.g., cutinase are inactivated by the reducing agents (DTT or beta-mercaptoethanol) used to generate free thiols, as shown in Example 10. If a reducing agent comprising a thiol group, is used to chemically generate free thiols in a protein, it must be removed before immobilisation by can be performed, during which step the disulfide bonds can reform.
- Immobilisation of a protein 6n a support can also be spatially controlled.
- Present day laser technology allow for focal spots with dimensions of 1 micrometer or less. If a specific protein or target molecule, containing SS bridge(s), is incubated with a thiol-binding support, light-induced thiol group formation and coupling could be limited to the focal points of illumination.
- the viscosity of the solution should be controlled to minimise diffusive processes that might disperse the illuminated molecules beyond the spot size. This approach would allow for an extremely dense packing of identifiable and different molecules on a support surface.
- the method of the present invention could be used for charging microarrays with molecules.
- the orientation of the immobilized protein can be controlled in a uniform and reproducible manner. Prolonged selective excitation of tryptophan residues in a protein will only lead to disruption of those disulfide bridges to which excitation energy is transferred.
- the location of these photo-disruptable disulfide bridges, forming free thiol groups, can be predicted from the protein's structure, where it is known from three-dimensional models, nuclear magnetic resonance (NMR) or X-ray diffraction crystallography analysis.
- cutinase Since cutinase has only a single thiol group for immobilisation, which is distant from the active site, the accessibility of substrates will not be limited by immobilisation. Immobilisation via a surface accessible thiol group, remote from the protein's active site, as is the case for cutinase and lysosyme, is also less likely to alter the conformation or structural properties of the protein. In other words, the immobilisation method of the present invention serves to preserve the native state of the immobilised protein. All functional/structural assays performed on proteins, which are immobilised in a uniform orientation according to the methods of the present invention, will generate data derived from a uniform population of proteins.
- the structural and functional uniformity of the immobilised proteins, and retention of their native state, is of primary importance for screening or assaying proteins for catalytic, binding, or any other biological properties and provides one of the many valuable advantages of the present invention.
- proteins such as lysosyme, which have anti-microbial properties, it is useful to be able to immobilise said proteins on a surface (e.g. food, skin, packaging) in order to prevent microbial growth and infection.
- the bond immobilising the protein to the support can be disrupted, releasing the protein into solution.
- Disulfide bridges between a protein and a support can be disrupted e.g. with UV irradiation, in ⁇ the same way as disrupting a disulfide bond on a protein, where an aromatic amino acid is a spatial neighbour.
- the aromatic amino acid can either be located on the immobilised protein itself, or be supplied in the form of a solution of an aromatic amino acid, such as tryptophan, applied to the support surface.
- Disulphide bonds (SS) themselves are known to be disrupted by approximately 254nm light.
- disulfide bridges between a protein and a support can be disrupted with (dithiothreitol) DTT, or other reducing agents known to persons skilled in the art. Following disruption of the immobilisation bond, the released protein can be purified, if necessary, and used in further experiments.
- a further aspect of the present invention is regenerating a gold surface by removing proteins that are immobilized through a thiol-Au bond with 0 2 - plasma treatment or Piranha, thereby removing the top layer of the gold surface including the proteins.
- Example 1 Formation of free thiol groups in cutinase upon UV illumination The disruption of disulfide bridges in a protein following UV illumination was examined using a cutinase, with lipase/esterase properties isolated from Fusarium solani pisi.
- Cutinase preparations were subjected to UV irradiation at 295 nm under the following conditions in order to follow its steady-state fluorescence emission intensity of continuous illumination: Three ml of 2 ⁇ M stock solution of cutinase was continuously illuminated at 295 nm for increasing periods of time (Oh, 1 h, 2h, 3h, 4h, and 5h) in a quartz macro-cuvette (1 cm path length). Light excitation at 295 nm was supplied by a Xenon Arc Lamp coupled to a monochromator provided by a RTC 2000 PTI spectrometer. The cuvette was mounted in a thermostated cuvette, kept at a constant temperature of 25°C.
- the cutinase sample was maintained as a homogeneous solution by continuous stirring at 700 rpm with a magnet. Excitation and emission slits were set at 6 nm. The fluorescence intensity of cutinase at 350 nm was continuously monitored throughout 5h of illumination. The time dependent fluorescence emission intensity of a 2 ⁇ M cutinase solution at 350 nm upon illumination with 295nm light is shown in Figure 1. Fluorescence intensity increased very rapidly over the first 7200s, followed by a plateau where the fluorescence yield appeared to stabilise.
- the concentration of free thiol groups in cutinase formed following UV illumination was determined as follows: Thiol groups on the cutinase were detected and quantified by a spectrophotometric assay based on the reaction of thiol groups with 5,5'-dithiobis-(2-nitrobenzoic acid) [DTNB], as shown in figure 2, or Ellman's reagent (Ellman GG,. 1959 Arch. Biochem. Biophys. 82: 70-77; Hu ML., 1994, Meth. Enzymology 233: 380-385).
- the control sample comprised 100 ⁇ l of a 8.5mM DTNB stock solution in absolute methanol mixed with 900 ⁇ l of non-irradiated cutinase (17.3 ⁇ M cutinase solution in 20mM TrisHCI pH 8.5).
- the concentration of illuminated cutinase sample was raised to ensure that the amount of free thiol groups formed upon illumination were above the detection limit of the DTNB method.
- Example 2 Irradiation-induced disruption of a disulfide bridge in native cutinase is dependent on the presence of a Trp residue as spatial neighbour
- Trp fluorescence emission intensity of the native protein was compared to that of reduced cutinase in which all disulfide bridges were chemically disrupted.
- the cutinase protein was partially denatured by heat in order to facilitate reduction of all its disulfide bridges.
- Trp fluorescence emission intensity of the native and denatured cutinase was used to demonstrate the importance of a Trp residue being a spatial neighbour of a disulfide bridge, for the transfer of excitation energy from Trp to the disulfide bridge.
- the disulfide bridges within the folded protein are inaccessible to solvent, and they cannot be directly reduced by DTT.
- the heat denaturation step was performed on a dilute solution of cutinase, in order to avoid precipitation of the protein.
- the buffer (20mM Tris-HCI 8.5) selected for the heat denaturation of cutinase, displays a minimal pH drift in relation to temperature and volume changes, and furthermore Tris-HCI has minimal enthalpy of ionisation.
- the concentration of cutinase solutions was estimated from the OD 280nm of the solution, using the extinction coefficient of cutinase at 280nm (13500 M "1 cr ⁇ 1 ).
- the four emission spectra are shown in Figure 4.
- the emission spectrum of cutinase incubated at 25°C (A) is the same as the emission spectrum of cutinase after cooling from 70°C to 25°C (C), demonstrating that thermal unfolding of cutinase at pH 8.5 is a reversible process. This can be compared with the emission spectrum of cutinase in an unfolded state (B).
- the Trp emission fluorescence intensity of cutinase at 25°C, after heating to 70°C in the presence of DTT (D) was greater than for native cutinase without DTT, as in (A).
- Example 3 Specificity of light-induced disulphide bridge disruption in proteins
- the cutinase gene of Fusarium solani pisi has been mutated to encode a mutant cutinase polypeptide where the single tryptophan residue is replaced by alanine, a non-fluorescent amino acid (W69A).
- W69A a mutant cutinase polypeptide where the single tryptophan residue is replaced by alanine, a non-fluorescent amino acid
- the mutant cutinase (W69A) was expressed recombinantly.
- DTNB detectable thiol groups in native cutinase following UV irradiation provides an additional tool for quantitating the disruption of disulfide bridges. Following UV illumination only one thiol group per cutinase molecule was detected. This is consistent with the disruption of the surface localised disulfide bond, where the second thiol group is not solvent accessible. At least one of the cystine residues of the second disulfide bridge is solvent accessible, but disruption was not detected.
- Example 4 Prediction of proteins with light-inducible Trp-SS triads Proteins comprising disulfide bridge(s) and aromatic residue(s), wherein a carbon or nitrogen atom in the indole ring of a selected (trp) residue lies within, or less than, 5 A from the S atoms of a disulfide bridge were identified in the Protein Data Bank of the Research Collaboration for Structural Bioinformatics (RCSB) (Bergman et al. 2000, Nucleic Acids Research, 28: 235-242). Only those proteins for which either NMR or X- ray crystal structures were available were considered.
- RCSB Structural Bioinformatics
- the distances between the atoms of the triad were measured using the molecular visualization program: Deep View/Swiss-Pdb Viewer at www.expasy.org. spdbv (Guex, N and Peitsch, M.C., 1997, Electrophoresis 18: 2714-2723).
- the selected proteins were matched against a sorted list of proteins having less than a 90% sequence identity and belonging to each of the different enzyme classes [EC Number and classification]. For the purposes of this analysis those proteins (hydrolases) in which the trp-SS triad was located in a ligand were not considered. Furthermore, triads occurring more than once in a PDB entry due to molecule dimers, trimers, etcetera or repetitions of the molecule in the unit cell were only considered once.
- Trp-SS triads were found to be common among hydrolase enzymes, of which cutinase is a member.
- the amino acid residues located within an 8A, 12A and 15A radius of the Trp-SS triad(s) identified in each of these proteins (where the centre of the spherical area is the indole ring of the tryptophan located closest to the disulfide bond) was calculated and grouped according to their properties: Gly, Ala, Val (short aliphatic); Leu, lie (long aliphatic); Pro; Ser,Thr (hydroxyl-containing); Cys, Met (sulfur-containing); Asn, Gin (amidic); Asp, Glu (acidic); His, Lys, Arg (basic); Phe, Tyr, Trp (aromatic).
- t[cut] and t[n] denotes the triad of cutinase and the triad n respectively, and is the standard deviation of the triad in consideration.
- the correlation coefficients were used to sort the triads with respect to their similarity to cutinase.
- the graphical representation of the result was made as a contour plot of the scores with the scores less than one representing groups of residues occurring less than expected and scores of one and higher representing groups of residues occurring at expected and more than expected frequencies.
- amidic amino acids (Asn, Gin) and the occurrence of aliphatic residues are also over-represented in the many immunoglobulins whose amino acid composition around the TrpSS spatial triad closely resembles the composition around the cutinase triad (immunoglobulins part of the IGG1 triads A group).
- immonuglobulins we also observe an under-representation of the groups of charged amino acids (His, Lys, Arg)(Asp, Glu) and proline residues ( Figures 11 and 12).
- Trp-SS triads in which the angle between the plane of the emitting dipole of the aromatic Trp side chain is orthogonal to the plane of the absorbing dipole of the disulfide bridge are unlikely to exchange excitation energy between excited state Trp and a disulfide bridge.
- Trp- SS triads The following proteins: hen egg white lysosyme, Rhizopus niveus triglyceride lipase, human plasminogen, human placental alkaline phosphatase, chymosin B, and human immunoglobulin were all shown to comprise light-inducible Trp- SS triads, as shown in Figure 8 A-F.
- the protein alpa-lactalubumin comprises 4 disulfide bridges, of which only two are disrupted on UV illumination, namely Cys6-Cys120 and Cys73- Cys91 (Vanhooren et al ⁇ 2002) Biochemistry, 41 (36): 11035-11043). Although both Cys73-Cys91 and Cys28-Cys11 in alpha-lactalbumin have at least one sulphur atom located within 4A of the nearest atom of a tryptophan indole ring, only the former is susceptible to light-induced disruption.
- the triad Trp60-Cys73-Cys9 is located within an 8A radius spherical area whose amino acid composition is similar to that of the cutinase triad, particularly with regards the abundance of the (Phe, Tyr, Trp), (Asp, Glu), (Asn, Gin) and Pro residues (Figure 10).
- Example 5 Light induced cutinase coupling.
- the coupling reaction was performed as follows. Three ml of a 17.3 ⁇ M solution of cutinase in 20mM TrisHCI pH 8.5 was illuminated with 295nm light in a quartz macro-cuvette (1 cm path length) for different periods of time using a RTC 2000 PTI spectrometer, as described in example 1 and 2. An excess of DTNB (100 ⁇ l of an ⁇ .5mM DTNB stock solution in absolute methanol) was added to 900 ⁇ l of cutinase solution, prior to or after its illumination at 295 nm.
- control sample comprised 100 ⁇ l of an 8.5mM DTNB stock solution in absolute methanol mixed with 900 ⁇ l of non-irradiated cutinase (17.3 ⁇ M cutinase solution in 20mM Tris-HCI pH 8.5).
- the free reactive thiol groups formed in a protein e.g. cutinase from Fusarium solani pisi, in response to illumination are used to link the protein to a thiol reactive support or carrier molecule, whether it be gold, or gold derivatised with thiol groups, or quartz surfaces derivatised with SH groups, or a polymer support or carrier molecule derivatised with SH groups.
- the immobilised proteins are shown to retain their functional properties (e.g. enzymatic).
- a polymer support is derivatized with SH groups by first activating with NHS/EDC which modifies carboxymethyl groups to N-hydroxysuccinimide esters.
- a thiol group is then introduced on the support by incubation with cysteamine in 0.1 M borate buffer pH 8.0 and subsequently with DTT or DTE (dithioerythritol) in 0.1 M borate buffer pH ⁇ .0.
- the support is flushed with 0.1 M borate buffer pH ⁇ .0 prior to immobilization.
- Proteins may also be linked to a quartz support, derivatised with SH groups, and the immobilisation monitored by Total Internal Refection Fluorescence (TIRF) spectroscopy, as exemplified for an number of proteins, using the following procedure:
- TIRF Total Internal Refection Fluorescence
- Step 1 Surface preparation of quartz slides for TIRF spectroscopy
- the quartz slide (12 cm 2 ) was cleaned by immersion in chromosulfuric acid (Merck 1.02499/Z624399) for 1 hour at 70-75 °C, and then rinsed in water at ambient temperature.
- the slide was then hydroxylated by immersion in 5 w/v% potassium persulfate (99% K 2 S 2 0 8 , Acros Organics 20201-000) in de- ionised H 2 0 for 1 hour at 99-100° C, in order to increase the number of OH groups.
- the hydroxylated slides were rinsed with deionised H 2 0 and dried rapidly.
- SH-activated slides are then prepared by applying 150 ⁇ l 0.03% v/v 3- mercaptopropyl-trimethoxysilane (Merck 63300) in m-xylene (99+%, Acros Organics 1306600100) to the hydroxylated slide.
- the xylene solvent was allowed to evaporate completely from the slide, and the surface was then flushed successively with pure xylene; ethanol and deionised H 2 0, and finally dried to yield a uniform, optically perfect silane coating.
- Step 2 Protein immobilisation on quartz slides by TIRF spectroscopy
- the SH-activated, or control hydroxylated, slide was mounted on the quartz prism with glycerol, and attached to the flow chamber with a 10 ⁇ m polyurethane gasket, and assembled in the TIRF instrument coupled to a fluorescence spectrophotometer, supplied with a 75W xenon arc source.
- Protein immobilisation was performed by flushing the flow chamber at a flow rate of 0.25 ml "1 , or incubating with the following solutions: a) 25 mM Tris-HCL, pH 8.5 (buffer A), for 5 -10 min, to hydrate the slide.
- Non-ionic detergent e.g. 2 v/v% Helmanex II (Hellma GmbH & Co KH,
- Protein immobilisation was performed under conditions of continuous UV illumination, limited UV illumination (10 min light, or 1 sec light/min) at 280 or 296 nm, or darkness (control) and was monitored by fluorescence emission at 330nm.
- the slides were rinsed with ethanol and H 2 0 before measuring immobilised protein activity.
- the protein sample e.g., 2 ⁇ M cutinase solution
- the protein sample is UV-irradiated and subsequently immobilised on the SH- derivatised quartz slide by incubation and/or flushing with the sample, followed by purging with buffer A, and optionally a detergent to remove unbound protein.
- Step 3 Enzymatic activity of immobilised activity A fluorogenic enzyme substrate was applied to the quartz slide following the immobilisation procedure, and the reaction products were detected by fluorescence spectroscopy.
- Lysozyme immobilisation was shown to be light-activated and to be dependent on SH-activation of the quartz slide ( Figure 16A versus B). The coupling efficiency of lysosyme immobilisation was found to be enhanced if the continuous illumination was limited to 10 min. Chymosin immobilisation was similarly found to be light activated and dependent on coupling to an SH- quartz surface ( Figure 16 C).
- lysozyme activity immobilised on a quartz slide was detection according to the procdure used for the detection of cutinase activity, with the exception that a lysozyme-specific substrate was used (EnzCheck Lysozyme, 22013, Molecular probes Inc), and that the fluorescence signal was recorded spectrometrically.
- a drop of 125 ⁇ L of 50 ⁇ g/ml substrate (in 0.1 M Phosphate / 0.1 M NaCI pH 7.5) was applied on the quartz slide. After 30 minutes incubation of at ambient room temperature (20-25°C), 100 ⁇ L of the solution was transferred to a well in a black multiplate (96 wells, Nunc 267742).
- Lysozyme activity analysis also showed show larger activity on SH-activated slides with UV-illumination compared to the controls, comprising immobilisation/adsorption on SH-activated slides in dark, or on hydroxylated slides with UV.
- Proteolytic digestion of immunoglobulin IgG complexes with papain generates two F(ab) fragments, each comprising two polypeptides.
- the available 3D structures of domains of Fab fragments of IgG immunoglobulins shows that all of them are rich in Trp/Cys-Cys triads.
- the available 3D structures of Fab fragments show that the intra-domain disulphide bridges present in the CH, VH, CL, anc V ⁇ _ domains are not solvent accessible.
- An additional inter-domain disulphide bridge is present connecting consented regions at the base of the Fab fragment, located far from the antigen biding site. This disulphide bridge is solvent accessible and located nearby a Trp residue.
- Orientated immobilisation of F(ab) fragments on an SH-group derivatised support can be achieved by UV-induced disruption of a disulfide bridge of the F(ab) fragment, e.g. the C-terminal interdomain disulfide bridge (Cys136- Cys214) of 1CBV mouse lgG1 F(ab), which lies within 10-11 A of Trp196.
- the antigene binding site located at the other end of the Fab fragment, will be remote from the site of immobilisation and thus maintain its availability to antigene recognition.
- Aromatic amino acids can be included in the immobilisation buffer to facilitate light-induced disruption of inter- or intra-domain disulfide bridges of a protein that are not in proximity of an endogenous aromatic amino acid, which can also be usefully employed to the immobilisation of immunoglobulin F(ab) fragments.
- the specificity of coupling is tested by performing control immobilisation assays in the dark and on a hydroxylated support. Fluorescence emission at 330nm on excitation at 296nm, provides a measure of F(ab) immobilised on the slide.
- the antigen binding activity of F(ab) fragments, immobilised in step (b) is determined by introducing an anti-mouse IgG F(ab) specific fluorescein isothiocyanate conjugate (Sigma F2653) diluted 100x in
- Glucose oxidase is used to quantitate ⁇ -D-glucose in liquids (e.g. human blood).
- Glucose oxidase comprises a solvent accessible trp-SS triad (Cys164-Cys206) located 7-9A from Trp133, and light-induced disruption of this disulfide bridge creates a thiol group suitable for coupling to a carrier. Since the disulfide bridge is positioned remote from the active site, its disruption, and the subsequent coupling of the generated thiol to a support , will not impair the catalytic activity of glucose oxidase. Immobilisation of a 2 ⁇ M glucose oxidase solution on quartz slides is performed and monitored by TIRF spectroscopy as described above for cutinase.
- Example 7 Spatially controlled protein immobilisation
- Cutinase molecules were immobilised on SH-activated quartz slides, spatially confined to an area of 1-2 ⁇ m 2 .
- a droplet of a 5 ⁇ M cutinase solution in 25mM Tris-HCI pH 8.5 was deposited on the SH-activated quartz slide at room temperature.
- the droplet was illuminated with laser light of 296nm, whereby the tip of the laser probe was submerged in the droplet and positioned 1-2mm above the activated quartz surface.
- Immobilised cutinase activity was detected on the slide surface, in a spatially confined area, using the cutinase assay given in Example 6 A.
- UV light is used to release a protein e.g. a cutinase enzyme, disulfide bonded to a thiol reactive surface by light-induced immobilisation.
- a protein e.g. a cutinase enzyme, disulfide bonded to a thiol reactive surface
- UV light irradiation is released by UV light irradiation according to the following steps:
- the cutinase enzyme disulfide bonded to a thiol reactive surface by light- induced immobilisation, is released by chemical reduction of disulfide bonds. Thereafter, the protein is dialysed in a 20mM Tris-HCI pH3.5 buffer, free of reducing agents, to regain its native structure.
- the immobilised cutinase is released by a reducing agent according to the following steps:
- Example 10 Effect of light irradiation or a reducing agent of protein function and stability
- a protein sample (cutinase) illuminated at 296 nm showed no decrease in activity compared to a protein sample placed in darkness or in normal
- Cutinase (1 ⁇ M in 25 mM Tris pH 3.5) was illuminated in a PTI fluorescence spectrometer (excitation slit was set at 6nm and emission slit were set at Vz nm). 3ml sample was placed in a quartz cuvette and was continuously stirred
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Computational Biology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Inorganic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006500512A JP2006515677A (en) | 2003-01-22 | 2004-01-22 | Light-induced immobilization |
EP04704181A EP1587839B1 (en) | 2003-01-22 | 2004-01-22 | Light induced immobilisation |
US10/542,159 US20060153922A1 (en) | 2003-01-22 | 2004-01-22 | Light induced immobilisation |
AU2004205725A AU2004205725A1 (en) | 2003-01-22 | 2004-01-22 | Light induced immobilisation |
DK04704181T DK1587839T3 (en) | 2003-01-22 | 2004-01-22 | Light-induced immobilization |
DE602004016955T DE602004016955D1 (en) | 2003-01-22 | 2004-01-22 | LIGHT-INDUCED IMMOBILIZATION |
CA002513265A CA2513265A1 (en) | 2003-01-22 | 2004-01-22 | Light induced immobilisation |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44197503P | 2003-01-22 | 2003-01-22 | |
US60/441,975 | 2003-01-22 | ||
DKPA200300081 | 2003-01-22 | ||
DKPA200300081 | 2003-01-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004065928A2 true WO2004065928A2 (en) | 2004-08-05 |
WO2004065928A3 WO2004065928A3 (en) | 2004-09-10 |
Family
ID=32773409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DK2004/000047 WO2004065928A2 (en) | 2003-01-22 | 2004-01-22 | Light induced immobilisation |
Country Status (9)
Country | Link |
---|---|
US (1) | US20060153922A1 (en) |
EP (1) | EP1587839B1 (en) |
JP (1) | JP2006515677A (en) |
AT (1) | ATE410450T1 (en) |
AU (1) | AU2004205725A1 (en) |
CA (1) | CA2513265A1 (en) |
DE (1) | DE602004016955D1 (en) |
DK (1) | DK1587839T3 (en) |
WO (1) | WO2004065928A2 (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007000163A1 (en) * | 2005-06-27 | 2007-01-04 | Bionanophotonics A/S | Immobilisation of polypeptides by irradiation |
JP2007182421A (en) * | 2005-12-09 | 2007-07-19 | National Institute Of Advanced Industrial & Technology | Materials to promote freezing of water or water |
FR2898903A1 (en) * | 2006-03-24 | 2007-09-28 | Oreal | New thiol/disulfide naphthylimide fluorescent compounds useful to make a tinctorial composition for human keratinous fibers, particularly for lightening hair |
WO2008077406A2 (en) * | 2006-12-22 | 2008-07-03 | Aalborg Universitet | Coupling of elements |
WO2008077407A1 (en) * | 2006-12-22 | 2008-07-03 | Aalborg Universitet | Light induced material deposition by molecular immobilization |
EP2114820A2 (en) * | 2006-12-28 | 2009-11-11 | University Of Maryland Biotechnology Institute | Metal coated virus-based nanoelectrodes and method of assembling of same |
US8383237B2 (en) | 2009-06-01 | 2013-02-26 | University Of Maryland, College Park | Preparation of silica stabilized biological templates for the production of metal and layered nanoparticles |
EP2727999A1 (en) * | 2012-11-01 | 2014-05-07 | Chung Yuan Christian University | Immobilized enzyme and its fabrication method and reaction system |
WO2015132350A1 (en) * | 2014-03-05 | 2015-09-11 | Commissariat À L' Energie Atomique Et Aux Energies Alternatives (Cea) | Method for photo-immobilizing biomolecules on a non-functionalized carrier |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3877752A1 (en) | 2018-11-05 | 2021-09-15 | Toray Films Europe | Fluorescence spectroscopic method |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3959078A (en) * | 1973-05-18 | 1976-05-25 | Midwest Research Institute | Enzyme immobilization with a thermochemical-photochemical bifunctional agent |
WO1991016425A1 (en) * | 1990-04-12 | 1991-10-31 | Hans Sigrist | Method for the light-induced immobilization of biomolecules on chemically 'inert' surfaces |
WO1994001773A1 (en) * | 1992-07-06 | 1994-01-20 | Biomira Inc. | Photoactivation of proteins for conjugation purposes |
US5412087A (en) * | 1992-04-24 | 1995-05-02 | Affymax Technologies N.V. | Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces |
US6350368B1 (en) * | 1996-05-27 | 2002-02-26 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Electrochemical and photochemical electrodes and their use |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6406844B1 (en) * | 1989-06-07 | 2002-06-18 | Affymetrix, Inc. | Very large scale immobilized polymer synthesis |
JPH05209884A (en) * | 1991-10-11 | 1993-08-20 | Tdk Corp | Method for detecting antigen and antibody |
-
2004
- 2004-01-22 AT AT04704181T patent/ATE410450T1/en not_active IP Right Cessation
- 2004-01-22 WO PCT/DK2004/000047 patent/WO2004065928A2/en active Search and Examination
- 2004-01-22 DK DK04704181T patent/DK1587839T3/en active
- 2004-01-22 JP JP2006500512A patent/JP2006515677A/en active Pending
- 2004-01-22 EP EP04704181A patent/EP1587839B1/en not_active Expired - Lifetime
- 2004-01-22 US US10/542,159 patent/US20060153922A1/en not_active Abandoned
- 2004-01-22 DE DE602004016955T patent/DE602004016955D1/en not_active Expired - Fee Related
- 2004-01-22 AU AU2004205725A patent/AU2004205725A1/en not_active Abandoned
- 2004-01-22 CA CA002513265A patent/CA2513265A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3959078A (en) * | 1973-05-18 | 1976-05-25 | Midwest Research Institute | Enzyme immobilization with a thermochemical-photochemical bifunctional agent |
WO1991016425A1 (en) * | 1990-04-12 | 1991-10-31 | Hans Sigrist | Method for the light-induced immobilization of biomolecules on chemically 'inert' surfaces |
US5412087A (en) * | 1992-04-24 | 1995-05-02 | Affymax Technologies N.V. | Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces |
WO1994001773A1 (en) * | 1992-07-06 | 1994-01-20 | Biomira Inc. | Photoactivation of proteins for conjugation purposes |
US6350368B1 (en) * | 1996-05-27 | 2002-02-26 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Electrochemical and photochemical electrodes and their use |
Non-Patent Citations (3)
Title |
---|
COLLIOUD A ET AL: "ORIENTED AND COVALENT IMMOBILIZATION OF TARGET MOLECULES TO SOLID SUPPORTS: SYNTHESIS AND APPLICATION OF A LIGHT-ACTIVATABLE AND THIOL-REACTIVE CROSS-LINKING REAGENT" BIOCONJUGATE CHEMISTRY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, US, vol. 4, no. 6, 1993, pages 528-536, XP001121631 ISSN: 1043-1802 cited in the application * |
DOSE K: "The Photolysis of Free Cystine in the Presence of Aromatic Amino Acids" PHOTOCHEMISTRY AND PHOTOBIOLOGY, vol. 8, 1968, pages 331-335, XP008032773 * |
NEVES-PETERSEN MT ET AL.: "High probability of disrupting a disulphide bridge mediated by an endogenous excited tryptophan residue" PROTEIN SCIENCE, vol. 11, 2002, pages 588-600, XP002288112 cited in the application * |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007000163A1 (en) * | 2005-06-27 | 2007-01-04 | Bionanophotonics A/S | Immobilisation of polypeptides by irradiation |
JP2007182421A (en) * | 2005-12-09 | 2007-07-19 | National Institute Of Advanced Industrial & Technology | Materials to promote freezing of water or water |
EP1829890A1 (en) | 2005-12-09 | 2007-09-05 | National Institute of Advanced Industrial Science and Technology | Material for promoting the freezing of water or hydrous substance |
US7700718B2 (en) | 2005-12-09 | 2010-04-20 | National Institute Of Advanced Industrial Science And Technology | Material for promoting the freezing of water or hydrous substance |
FR2898903A1 (en) * | 2006-03-24 | 2007-09-28 | Oreal | New thiol/disulfide naphthylimide fluorescent compounds useful to make a tinctorial composition for human keratinous fibers, particularly for lightening hair |
WO2008077406A3 (en) * | 2006-12-22 | 2008-08-21 | Bionanophotonics As | Coupling of elements |
WO2008077407A1 (en) * | 2006-12-22 | 2008-07-03 | Aalborg Universitet | Light induced material deposition by molecular immobilization |
WO2008077406A2 (en) * | 2006-12-22 | 2008-07-03 | Aalborg Universitet | Coupling of elements |
EP2114820A2 (en) * | 2006-12-28 | 2009-11-11 | University Of Maryland Biotechnology Institute | Metal coated virus-based nanoelectrodes and method of assembling of same |
EP2114820A4 (en) * | 2006-12-28 | 2010-04-21 | Univ Maryland Biotech Inst | VIRUS-BASED METAL-COATED NANOELECTRODES AND METHOD FOR ASSEMBLING THE SAME |
US8617869B2 (en) | 2006-12-28 | 2013-12-31 | University Of Maryland, College Park | Metal coated virus-based nanoelectrodes and method of assembling of same |
US8383237B2 (en) | 2009-06-01 | 2013-02-26 | University Of Maryland, College Park | Preparation of silica stabilized biological templates for the production of metal and layered nanoparticles |
EP2727999A1 (en) * | 2012-11-01 | 2014-05-07 | Chung Yuan Christian University | Immobilized enzyme and its fabrication method and reaction system |
WO2015132350A1 (en) * | 2014-03-05 | 2015-09-11 | Commissariat À L' Energie Atomique Et Aux Energies Alternatives (Cea) | Method for photo-immobilizing biomolecules on a non-functionalized carrier |
Also Published As
Publication number | Publication date |
---|---|
DK1587839T3 (en) | 2009-02-16 |
ATE410450T1 (en) | 2008-10-15 |
JP2006515677A (en) | 2006-06-01 |
AU2004205725A1 (en) | 2004-08-05 |
US20060153922A1 (en) | 2006-07-13 |
DE602004016955D1 (en) | 2008-11-20 |
CA2513265A1 (en) | 2004-08-05 |
EP1587839A2 (en) | 2005-10-26 |
EP1587839B1 (en) | 2008-10-08 |
WO2004065928A3 (en) | 2004-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10852305B2 (en) | Molecules and methods for iterative polypeptide analysis and processing | |
Neves‐Petersen et al. | Photonic activation of disulfide bridges achieves oriented protein immobilization on biosensor surfaces | |
Zhu et al. | Enzymatic profiling system in a small-molecule microarray | |
WO2008077406A2 (en) | Coupling of elements | |
Urbina et al. | Self‐assembled small‐molecule microarrays for protease screening and profiling | |
EP2211177A1 (en) | Methods using O6-alkylguanine-DNA alkyltransferases | |
JP2004532028A5 (en) | ||
EP1587839B1 (en) | Light induced immobilisation | |
US20130338044A1 (en) | Bioconjugation using bifunctional linkers | |
Wei et al. | Adsorption-induced changes in ribonuclease A structure and enzymatic activity on solid surfaces | |
Zhou et al. | Site-selective protein immobilization by covalent modification of GST fusion proteins | |
Wu et al. | DNA-directed trypsin immobilization on a polyamidoamine dendrimer-modified capillary to form a renewable immobilized enzyme microreactor | |
Fauser et al. | Sortase-mediated quantifiable enzyme immobilization on magnetic nanoparticles | |
WO2023049177A1 (en) | Single-molecule protein and peptide sequencing | |
Singhal et al. | Epitope imprinted polymeric materials: application in electrochemical detection of disease biomarkers | |
US20100216969A1 (en) | Immobilisation of polypeptides by irradiation | |
KR101502204B1 (en) | Method for detecting and quantifying target proteins | |
Nechifor et al. | Crosslinking of translation factor EF-G to proteins of the bacterial ribosome before and after translocation | |
Voelker et al. | Self-catalyzed immobilization of GST-fusion proteins for genome-encoded biochips | |
Kuramochi et al. | Affinity capture of a mammalian DNA polymerase β by inhibitors immobilized to resins used in solid-phase organic synthesis | |
KR20110080249A (en) | Live Cell Activity Assay | |
Højlys-Larsen et al. | Probing protein phosphatase substrate binding: affinity pull-down of ILKAP phosphatase 2C with phosphopeptides | |
CN1764671A (en) | Light induced immobilisation | |
Furuhata et al. | Chemical Diversification of Enzymatically Assembled Polyubiquitin Chains to Decipher the Ubiquitin Codes Programmed on the Branch Structure | |
Pagnozzi et al. | Stoichiometry and topology of the complex of the endogenous ATP synthase inhibitor protein IF1 with calmodulin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2513265 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004205725 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006500512 Country of ref document: JP |
|
WWP | Wipo information: published in national office |
Ref document number: 2004205725 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004704181 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20048078301 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2004704181 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2006153922 Country of ref document: US Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10542159 Country of ref document: US |
|
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWP | Wipo information: published in national office |
Ref document number: 10542159 Country of ref document: US |